China National Pharmaceutical Group Corporation (01099): The net profit attributable to shareholders of China National Pharmaceutical Group Limited in the first half of the year was 606 million yuan, a year-on-year decrease of 8.97%.

Zhitong Finance APP news, China National Pharmaceutical Group Co., Ltd. (01099) announced the semi-annual performance report of Sinopharm International for 2026, achieving operating revenue of 36.266 billion yuan, a year-on-year decrease of 1.44%; operating profit of 834 million yuan, a year-on-year decrease of 9.94%; total profit of 827 million yuan, a year-on-year decrease of 9.88%; net profit attributable to shareholders of the listed company of 606 million yuan, a year-on-year decrease of 8.97%, correspondingly, the basic earnings per share decreased by 9.17% year-on-year. Revenue and profit show a trend of narrowing decline compared to the first quarter, with the weighted average return on net assets decreasing by 0.49 percentage points year-on-year.